Non-histaminic angioedema management: diagnostic and therapeutic interest of tranexamic acid

被引:24
作者
Bouillet, L
Ponard, D
Douet, C
Massot, C
机构
[1] CHU Grenoble, Serv Med Interne, Dept Pluridisciplinaire Med, F-38043 Grenoble 09, France
[2] CHU Grenoble, Immunol Lab, F-38043 Grenoble 09, France
来源
REVUE DE MEDECINE INTERNE | 2004年 / 25卷 / 12期
关键词
angioedema; non histaminic; bradykinin; tranexamic acid;
D O I
10.1016/j.revmed.2004.07.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. - The diagnosis of chronic angioedema (localised and reversible oedema) is sometimes very difficult when there is no efficiency of anti-histaminics and corticosteroids. In these cases, bradykinin angioedema must be mentioned. Tranexamic acid is efficient and must be proposed. Study. - We reported seven patients who have a non-histaminergic angioedema since an average of 8 years. Corticosteroids and histamine-1 blockers were not efficient. Daily tranexamic acid treatment (1 g x 3 per day) controlled the disease. Three patients had no more attack. The C1 Inh antigen and function levels were normal. No secondary effect was described and all patients are still being treated (average of 20 months). Conclusion. - When a non-histaminergic angioedema is suspected, tranexamic acid must be proposed as attack's treatment and as prophylactic treatment. (C) 2004 Elsevier SAS. Tons droits reserves.
引用
收藏
页码:924 / 926
页数:3
相关论文
共 7 条
[1]   Non allergic angioedema: diagnosis and management [J].
Bouillet, L ;
Ponard, D ;
Drouet, C ;
Massot, C .
REVUE DE MEDECINE INTERNE, 2002, 23 (06) :533-541
[2]   Idiopathic nonhistaminergic angioedema [J].
Cicardi, M ;
Bergamaschini, L ;
Zingale, LC ;
Gioffré, D ;
Agostoni, A .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (06) :650-654
[3]   Bradykinin and the pathophysiology of angioedema [J].
Cugno, M ;
Nussberger, J ;
Cicardi, M ;
Agostoni, A .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (03) :311-317
[4]   ACTIVATION OF THE CONTACT SYSTEM AND FIBRINOLYSIS IN AUTOIMMUNE ACQUIRED ANGIOEDEMA - A RATIONALE FOR PROPHYLACTIC USE OF TRANEXAMIC ACID [J].
CUGNO, M ;
CICARDI, M ;
AGOSTONI, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (05) :870-876
[5]   Increased vascular permeability in C1 men inhibitor-deficient mice mediated by the bradykinin type 2 receptor [J].
Han, ED ;
MacFarlane, RC ;
Mulligan, AN ;
Scafidi, J ;
Davis, AE .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (08) :1057-1063
[6]   Plasma bradykinin in angio-oedema [J].
Nussberger, J ;
Cugno, M ;
Amstutz, C ;
Cicardi, M ;
Pellacani, A ;
Agostoni, A .
LANCET, 1998, 351 (9117) :1693-1697
[7]   TRANEXAMIC ACID THERAPY IN HEREDITARY ANGIONEUROTIC EDEMA [J].
SHEFFER, AL ;
ROSEN, FS ;
AUSTEN, KF .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (09) :452-&